Aalidhra Pharmachem Profile
Key Indicators
- Authorised Capital ₹ 1.00 Cr
as on 04-07-2024
- Paid Up Capital ₹ 9.00 M
as on 04-07-2024
- Company Age 9 Year, 8 Months
- Last Filing with ROC 31 Mar 2023
- Revenue 50.05%
(FY 2021)
- Profit 75.27%
(FY 2021)
- Ebitda 45.14%
(FY 2021)
- Net Worth 72.08%
(FY 2021)
- Total Assets 10.80%
(FY 2021)
About Aalidhra Pharmachem
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 1.00 Cr and a paid-up capital of Rs 9.00 M, as per Ministry of Corporate Affairs (MCA) records.
Hansrajbhai Gondalia and Prashant Gondalia serve as directors at the Company.
- CIN/LLPIN
U24230GJ2015PTC082779
- Company No.
082779
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
01 Apr 2015
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Ahmedabad
Industry
Company Details
- Location
Surat, Gujarat, India
- Telephone
- Email Address
- Website
- Social Media
What products or services does Aalidhra Pharmachem Private Limited offer?
Aalidhra Pharmachem Private Limited offers a wide range of products and services, including Pharma Ingredients & Raw Materials, Anti Infective API.
Who are the key members and board of directors at Aalidhra Pharmachem?
Board Members(2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Hansrajbhai Gondalia  | Director | 01-Apr-2015 | Current |
| Prashant Gondalia | Director | 24-Apr-2015 | Current |
Financial Performance of Aalidhra Pharmachem.
Aalidhra Pharmachem Private Limited, for the financial year ended 2021, experienced significant growth in revenue, with a 50.05% increase. The company also saw a substantial improvement in profitability, with a 75.27% increase in profit. The company's net worth Soared by an impressive increase of 72.08%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Aalidhra Pharmachem?
In 2021, Aalidhra Pharmachem had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Aalidhra Textool Engineers Private LimitedActive 34 years 5 monthsHansrajbhai Gondalia is a mutual person
Amit Machinary Manufacturers Private LimitedActive 35 years 3 monthsHansrajbhai Gondalia is a mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Aalidhra Pharmachem?
Aalidhra Pharmachem has a workforce of 163 employees as of Apr 08, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Aalidhra Pharmachem, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Aalidhra Pharmachem's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
